Predictors of autoimmune disease: Autoantibodies and beyond

Noel R. Rose

Research output: Contribution to journalArticle

Abstract

Increased emphasis has been placed in recent years on predictive biomarkers to foretell the onset or future course of disease. In autoimmune diseases, autoantibodies have proven to be valuable biomarkers because of their technical sensitivity, specificity, and stability during storage. Their predictive value is limited, however, by their prevalence. At present, predictive studies have utilized long-time evaluation of stable populations, families with one index case or retrospective investigations where large serum repositories are available. Our increasing knowledge of the steps leading from benign autoimmunity to frank autoimmune disease has suggested ways by which subtle genetic differences combined with assessment of the pattern of critical mediators can trace the progression of disease. The new tools of multiplex testing and information handling open opportunities to identify early signposts of disease.

Original languageEnglish (US)
Pages (from-to)419-428
Number of pages10
JournalAutoimmunity
Volume41
Issue number6
DOIs
StatePublished - 2008

Fingerprint

Autoantibodies
Autoimmune Diseases
Biomarkers
Population Dynamics
Autoimmunity
Disease Progression
Sensitivity and Specificity
Serum

Keywords

  • Biomarkers
  • Diabetes
  • Graves' disease
  • Lupus
  • Multiple sclerosis
  • Thyroiditis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Predictors of autoimmune disease : Autoantibodies and beyond. / Rose, Noel R.

In: Autoimmunity, Vol. 41, No. 6, 2008, p. 419-428.

Research output: Contribution to journalArticle

Rose, Noel R. / Predictors of autoimmune disease : Autoantibodies and beyond. In: Autoimmunity. 2008 ; Vol. 41, No. 6. pp. 419-428.
@article{e25a6ed235c245bfbc652ef60a0436b2,
title = "Predictors of autoimmune disease: Autoantibodies and beyond",
abstract = "Increased emphasis has been placed in recent years on predictive biomarkers to foretell the onset or future course of disease. In autoimmune diseases, autoantibodies have proven to be valuable biomarkers because of their technical sensitivity, specificity, and stability during storage. Their predictive value is limited, however, by their prevalence. At present, predictive studies have utilized long-time evaluation of stable populations, families with one index case or retrospective investigations where large serum repositories are available. Our increasing knowledge of the steps leading from benign autoimmunity to frank autoimmune disease has suggested ways by which subtle genetic differences combined with assessment of the pattern of critical mediators can trace the progression of disease. The new tools of multiplex testing and information handling open opportunities to identify early signposts of disease.",
keywords = "Biomarkers, Diabetes, Graves' disease, Lupus, Multiple sclerosis, Thyroiditis",
author = "Rose, {Noel R.}",
year = "2008",
doi = "10.1080/08916930802031686",
language = "English (US)",
volume = "41",
pages = "419--428",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Predictors of autoimmune disease

T2 - Autoantibodies and beyond

AU - Rose, Noel R.

PY - 2008

Y1 - 2008

N2 - Increased emphasis has been placed in recent years on predictive biomarkers to foretell the onset or future course of disease. In autoimmune diseases, autoantibodies have proven to be valuable biomarkers because of their technical sensitivity, specificity, and stability during storage. Their predictive value is limited, however, by their prevalence. At present, predictive studies have utilized long-time evaluation of stable populations, families with one index case or retrospective investigations where large serum repositories are available. Our increasing knowledge of the steps leading from benign autoimmunity to frank autoimmune disease has suggested ways by which subtle genetic differences combined with assessment of the pattern of critical mediators can trace the progression of disease. The new tools of multiplex testing and information handling open opportunities to identify early signposts of disease.

AB - Increased emphasis has been placed in recent years on predictive biomarkers to foretell the onset or future course of disease. In autoimmune diseases, autoantibodies have proven to be valuable biomarkers because of their technical sensitivity, specificity, and stability during storage. Their predictive value is limited, however, by their prevalence. At present, predictive studies have utilized long-time evaluation of stable populations, families with one index case or retrospective investigations where large serum repositories are available. Our increasing knowledge of the steps leading from benign autoimmunity to frank autoimmune disease has suggested ways by which subtle genetic differences combined with assessment of the pattern of critical mediators can trace the progression of disease. The new tools of multiplex testing and information handling open opportunities to identify early signposts of disease.

KW - Biomarkers

KW - Diabetes

KW - Graves' disease

KW - Lupus

KW - Multiple sclerosis

KW - Thyroiditis

UR - http://www.scopus.com/inward/record.url?scp=51849108657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849108657&partnerID=8YFLogxK

U2 - 10.1080/08916930802031686

DO - 10.1080/08916930802031686

M3 - Article

C2 - 18781467

AN - SCOPUS:51849108657

VL - 41

SP - 419

EP - 428

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 6

ER -